Bios Partners to Raise $50M Second Venture Capital Fund

Bios Partners, a Fort Worth, TX-based venture capital firm, is to raise its second fund.

Per an SEC filing, BIOS Fund II NT, LP is seeking to raise $50m.

Led by Aaron Fletcher and Leslie Kreis, Jr., Stella M. Robertson, Bios Partners focuses on making in investing in innovative early-stage and growth-stage biotech and medical device companies.

The firm’s portfolio already includes:
– Encore Vision
– Lung Therapeutics
– Cognition Therapeutics
– Actuate Therapeutics
– Azitra
– 410 Medical
– Abilitech Medical
– Lantern Pharma.

The team also includes:
– Travis M. Whitfill, MPH, Partner
– John Fucci, Associate
– Amanda De La Garza, Analyst
– Supriya Sinha, Analyst.



Join the discussion